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MaBACKGROUND Although efforts continue to ﬁnd new therapies to regenerate infarcted heart tissue, knowledge of the
cellular and molecular mechanisms involved remains poor.
OBJECTIVES This study sought to identify the origin of cardiac ﬁbroblasts (CFs) in the infarcted heart to better
understand the pathophysiology of ventricular remodeling following myocardial infarction (MI).
METHODS Permanent genetic tracing of epicardium-derived cell (EPDC) and bone marrow–derived blood cell (BMC)
lineages was established using Cre/LoxP technology. In vivo gene and protein expression studies, as well as in vitro cell
culture assays, were developed to characterize EPDC and BMC interaction and properties.
RESULTS EPDCs, which colonize the cardiac interstitium during embryogenesis, massively differentiate into CFs after
MI. This response is disease-speciﬁc, because angiotensin II–induced pressure overload does not trigger signiﬁcant EPDC
ﬁbroblastic differentiation. The expansion of epicardial-derived CFs follows BMC inﬁltration into the infarct site; the
number of EPDCs equals that of BMCs 1 week post-infarction. BMC-EPDC interaction leads to cell polarization, packing,
massive collagen deposition, and scar formation. Moreover, epicardium-derived CFs display stromal properties with
respect to BMCs, contributing to the sustained recruitment of circulating cells to the damaged zone and the cardiac
persistence of hematopoietic progenitors/stem cells after MI.
CONCLUSIONS EPDCs, but not BMCs, are the main origin of CFs in the ischemic heart. Adult resident EPDC contri-
bution to the CF compartment is time- and disease-dependent. Our ﬁndings are relevant to the understanding of post-MI
ventricular remodeling and may contribute to the development of new therapies to treat this disease. (J Am Coll Cardiol
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ABBR EV I A T I ON S
AND ACRONYMS
BMC = bone marrow–derived
cell
BZ = border zone
CD = cluster of differentiation
CF = cardiac ﬁbroblast
EPDC = epicardium-derived
cell
eYFP = enhanced yellow
ﬂuorescent protein
FACS = ﬂuorescence-activated
cell sorting
IZ = infarct zone
LT-HSC = long-term
hematopoietic stem cell
MI = myocardial infarction
mRFP = monomeric red
ﬂuorescent protein
RZ = remote zone
SDF = stromal cell–derived
factor
SMA = smooth muscle actin
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2058A ffecting millions of people, myocar-dial infarction (MI) is a leading causeof morbidity and mortality world-
wide (1). Given increasing pressure to ﬁnd
clinical alternatives to heart transplantation,
which is the only effective treatment for ter-
minal cardiac failure that often results from
MI, multiple researchers have sought to ﬁnd
an optimal cellular source to substitute
dead or damaged cardiomyocytes with new,
functional ones (2). However, knowledge of
the cellular and molecular mechanisms that
instruct and contribute to the normal, physio-
logical repair of the injured heart remains very
limited. This is paradoxical, because any ex-
perimental cell addition to the injured heart
will eventually interact with endogenous
cardiac reparative phenomena. Therefore,understanding such events is necessary to
identify an optimal time point to inject cells
with therapeutic properties into the damaged
organ, and to critically analyze the poor re-
SEE PAGE 2067sults so far reported by cell infusion–based clinical tri-
als attempting to ﬁx the infarcted heart (3).
During an MI, cardiac muscle death triggers an
acute inﬂammatory response, led by circulating, bone
marrow–derived blood cells (BMCs), which is fol-
lowed by the mobilization of cardiac ﬁbroblasts (CFs)
in the ischemic region (4,5). After an MI, activated
CFs expand to repair the injured area and deposit
large amounts of extracellular matrix components,
mainly collagen (6,7). This excessive deposition soon
transforms into a growing scar; this disrupts the ki-
netic properties of the myocardial walls, impairing
the mechanoelectric coupling of cardiomyocytes,
increasing the risk of arrhythmias (8,9), and eventu-
ally leading to heart failure.
Despite the enormous clinical relevance of CFs, not
much is known about their origin and biological
properties in the context of ischemic heart disease.
Interestingly, it has been suggested that character-
izing CF biology in relation to the cells’ origin could
be instrumental in deﬁning its genetic background
and potential response to normal and pathologic
conditions (10). Therefore, we aimed to identify the
origin of CFs in the infarcted heart and study their
interaction with BMCs during ﬁbrotic ventricular
remodeling.
METHODS
All animals used in this study were handled in
compliance with institutional and European Unionguidelines for animal care and welfare under a spe-
ciﬁc experimental procedure approved by the Ethics
Committee of the University of Málaga. Homozygote
Wt1/IRES/GFP-Cre (Wt1Cre) mice (Creþ/þ) were
crossed with B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J
mice (Rosa26R-eYFP, The Jackson Laboratory, Bay
Harbor, Maine). Wilm’s Tumor Gene 1 (Wt1)–driven
Cre activity mediates the excision of the LoxP-ﬂanked
STOP sequence in R26R mice, activating permanent
reporter enhanced yellow ﬂuorescent protein (eYFPþ)
expression in the Wt1þ cell lineage (Wt1Cre-YFPþ).
Routine tissue extraction, ﬁxation, and immuno-
histochemistry were performed as detailed in the
Online Appendix (antibodies used are listed in
Online Tables 1 and 2).
Wt1Cre-eYFPþ nonmyocardial cell suspensions
were washed in phosphate-buffered saline, and
incubated in 2% fetal bovine serum and 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
with the proper ﬂuorochrome-conjugated primary
immunoglobulin Gs (Online Table 3). Cell suspensions
were analyzed in a MoFlo cell sorter (DakoCytoma-
tion, Glostrup, Denmark).
For bone marrow transplantations, 12-week to
16-week-old C57/BL and Wt1Cre-eYFPþ host mice
were irradiated and transplanted with bone marrow
cells collected from monomeric red ﬂuorescent
protein (mRFP) donor mice, allowing for the full
reconstitution of the hematopoietic system of re-
cipient mice with constitutive mRFP-expressing
cells. One and 3 months after transplantation the
hematopoietic engraftment was analyzed by ﬂow
cytometry from peripheral blood samples via the
analysis of mRFP ﬂuorescence and antibodies
against cluster of differentiation (CD) 45.1/CD45.2
pan-leucocyte isoforms (BD Biosciences, San Jose,
California).
MI was induced by ligation of the left anterior
descending coronary artery of 20- to 24-week-old
mice as described elsewhere (11). Routine Mallory
trichrome staining was performed to evaluate ﬁbro-
sis, and samples were processed for immunohisto-
chemistry and eYFP/mRFP visualization as previously
mentioned.
Total ribonucleic acid from eYFPþ/CD31- cells sor-
ted from dissected sham, remote, and infarcted zones
was extracted using Tri-Reagent (Life Technologies,
Grand Island, New York) and polymerase chain reac-
tion performed in an Eco thermocycler (Illumina
Inc., San Diego, California) as indicated in the
Online Appendix.
Stromal cell–derived factor (SDF)-1a (R&D Systems,
Minneapolis, Minnesota, 0.1 mg/ml in Hank’s Balanced
Salt Solution, Life Technologies, Thermo Fisher
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2059Scientiﬁc Inc.,Waltham,Massachusetts) was delivered
to the ventricular walls of dissected Wt1Cre-eYFPþ
hearts by grafting SDF-1–embedded heparin-coated
acrylic beads (100 to 300 mm in diameter) into the
myocardium. Control beads were embedded in Hank’s
Balanced Salt Solution. Hearts were cultured for 8
hours in Dulbecco’s modiﬁed Eagle medium (Life
Technologies) and penicillin/streptomycin (37C; 5%
CO2), washed in phosphate-buffered saline, and ﬁxed
in fresh 4% paraformaldehyde. All samples were
counterstained with 40,6-diamidino-2-phenylindole
before eYFP inspection in an SP5 laser confocal mi-
croscope (Leica Microsystems, Buffalo Grove, Illinois).
For additional details on the experimental pro-
cedures, please refer to the Online Appendix.
RESULTS
The Wt1Cre-eYFPþ offspring displayed permanent
YFP reporter expression in the Wt1þ cell lineage
(from here onward referred to as eYFPþ; Figure 1A).
At embryonic days (E) 10.0 to 11.5, eYFPþ cells
formed the epicardial epithelium (Figures 1B to 1D).
Epicardial cell hypertrophy and generation of basal
ﬁlopodia/lamellipodia indicated that the epithelial
to mesenchymal transition that gives rise to
epicardium-derived cells (EPDCs) (12–14) was active
during this embryonic period (Figures 1C and 1D), but
not at later fetal, perinatal, or adult stages. After E11.5,
mesenchymal eYFPþ EPDCs invaded the ventricular
walls and occupied the nascent space between
myocardial ﬁbers, becoming the ﬁrst cells colonizing
the cardiac interstitium (Figures 1D to 1F). EPDC
interstitial homing was completed between E15.5 and
birth; eYFPþ EPDCs remained conspicuous in the
postnatal interstitium (Figures 1E to 1H).
Three eYFPþ EPDC subtypes can be identiﬁed. The
ﬁrst one associated to coronary endothelium (eYFPþ/
CD31þ/smoothmuscle actin, type a [a-SMA-], Figures 1I
and 1K), and the second one to coronary smooth
muscle (eYFPþ/CD31-/a-SMAþ, Figures 1J and 1K’’).
The third type of EPDC (eYFPþ/PECAM1-/a-SMAlow/-)
displayed a characteristic spindle-shaped mor-
phology and homes at the cardiac interstitium
(Figures 1K and 1K’). These cells did not express
signiﬁcant amounts of ﬁbroblast markers, such as
collagen I (Figure 1K’’), Fsp1, or Ddr2 (Online
Figures 1A and 1B). To further characterize EPDC
contribution to the cardiac interstitium, nonmyo-
cardial cells from neonatal hearts were isolated and
analyzed by ﬂuorescence-activated cell sorting
(FACS). eYFPþ cells were 6.2  1.3% of the total
nonmyocardial cell pool, including 37.4  5.1%of CD31þ endocardial/coronary endothelial cells
(Figures 1L and 1M). One-half (51.1  4.9%) of eYFPþ
interstitial EPDCs were endocardial/coronary endo-
thelial cells (CD31þ), whereas only 22.6  3.5% of the
nonendothelial (CD31-) eYFPþ cell fraction expressed
the ﬁbroblast and mesenchymal stem cell–related
antigen CD90 (Figure 1M’) (15).
Because circulating BMCs have also been suggested
to differentiate into CFs (10,16), the pan-leukocyte
marker CD45 (17) was used to characterize BMC
contribution to the embryonic cardiac interstitium.
BMCs were rare in the early (E11.5 to E15.5) heart walls
(Online Figures 2A to 2E0), but their numbers pro-
gressively increased from E15.5 to perinatal stages.
Cardiac CD45þ cells retained a circulating phenotype
(Figure 1N), although some of them inﬁltrated the
cardiac interstitium of cardiac chambers and acquired
a fusiform phenotype (Figure 1N’). This late incorpo-
ration of blood-borne cells into the embryonic cardiac
interstitium was conﬁrmed by parabiotic experiments
in avian embryos (Online Figures 2F to 2M0).
After birth, BMC cardiac homing was traced via
mRFPþ bone marrow transplantation to wild-type
recipient mice. Two months after transplantation,
BMC contribution to the healthy adult cardiac inter-
stitium was low, but persistent (1.9  0.6% of non-
myocardial cells; Figures 1M and 1O). Noncirculating,
fusiform interstitial BMCs were CD45þ (Figure 1P),
distributed outside the intramyocardial coronary
capillary network (Figure 1Q), and accumulated
around coronary arteries (Figure 1R). Most of these
cells were immature myeloid precursors (Mac1þ/
Gr1þ), B cells (B220þ), and monocytes (Mac1þ/Gr1-)
(Online Figures 3D and 3F).
POST-MI VENTRICULAR REMODELING. To identify
the contribution of eYFPþ EPDCs to ventricular
remodeling and scarring and deﬁne how such
contribution is coordinated with the inﬂammatory
process that follows MI, we transplanted irradiated
Wt1Cre-YFPþ mice with mRFP bone marrow. After
reconstitution, these animals were submitted to
ligation of the left anterior descending coronary
artery to induce MI and ventricular remodeling was
studied 1, 3, 7, 14, and 30 days after the injury
(Figure 2A). These time points allowed for the
screening of the inﬂammatory, proliferative, and
maturation phases of MI in small mammals (6).
Left anterior descending ligation caused massive
myocardial death within the ﬁrst day after the dam-
age, inducing a fast increase of circulating mRFPþ
BMCs to the infarct zone (IZ), whereas eYFPþ EPDC
density remained similar to that of the remote, non-
infarcted zones (Figure 2B). No double mRFPþ/eYFPþ
FIGURE 1 EPDCs Pioneer Cardiac Interstitium Formation
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(A) Wt1Cre-YFP mice were generated with activated permanent reporter enhanced yellow ﬂuorescent protein (eYFPþYFPþ) expression. (B to D) Epicardium (Ep) and
epicardium-derived cells (EPDCs) (arrowheads) express YFP at embryonic day (E) 11.5. Embryonic (at E15.5 [E] and E17.5 [F]) and postnatal (G) eYFPþ EPDCs colonize the
ventricular myocardium. (H) The eYFPþ area is normalized with respect to the total DAPIþ area in different heart locations. Adult ventricular eYFPþ cells integrate into
coronary blood vessel endothelium (I to K; arrowheads), muscular wall (J, K, K’; arrowheads), or the cardiac interstitium (K and K’, arrow). This latter interstitial cell type
does not express collagen I (Col I), present in the subendocardium (K’’, arrowheads) or forming coronary vessels (K’’, arrows). (L) Cluster of differentiation (CD) 31þ cells
from adult hearts are 37% of the eYFPþ interstitial population. (M) Interstitial cells are CD90þ and CD44þ. FACS of total eYFPþ cells identiﬁes a putative CD90þ/CD31-
cardiac ﬁbroblast precursor population (M’). (N and N’) CD45þ cells are incorporated within the embryonic ventricular myocardium around E15.5. Transplanted adult
monomeric red ﬂuorescent protein (mRFPþ) bone marrow cells home at the cardiac interstitium (O to R); CD45þ cells (P) position themselves outside capillaries (Q),
and accumulate in the peri-coronary interstitium (R, arrowheads). Scale bars: B, 80 mm; C, D, I to K, 15 mm; E, 150 mm; F, 50 mm; F’, K’’, O, and Q, 30 mm; G, 5 mm;
N, 60 mm; N’ and R, 10 mm. CM ¼ compact myocardium; CoA ¼ coronary arteries; DAPI ¼ 4’,6-diamidino-2-phenylindole; eGFP ¼ enhanced green ﬂuorescent protein;
FACS ¼ ﬂuorescence-activated cell sorting; a-SMA ¼ smooth muscle actin, type a; TM ¼ trabecular myocardium; Wt1 ¼ Wilm’s Tumor Gene 1; YFP ¼ yellow ﬂuorescent
protein.
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FIGURE 2 Post-MI Time-Dependent EPDC and BMC Cell Lineage Contribution After MI
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(A)Wt1Cre-YFPþmice were irradiated with mRFP bone marrow; after reconstitution, these mice were submitted to ligation of the left anterior descending (LAD) coronary
artery to induce myocardial infarction (MI) and ventricular remodeling. Transverse sections of infarcted hearts show early mRFPþ bone marrow–derived cell (BMC)
inﬁltration, from 1 (B) to 3 days (C) post-MI. eYFPþ EPDC abundance between 7 (D) and 14 (E) days after MI is shown. Thinning of the left ventricular myocardial wall is
also evident (D and E compared with C). By 30 days post-MI (F), a full scar, mostly constituted of eYFPþ ﬁbrous tissue (blue), is formed (F’, IZ; F’’, BZ). BMCs (mRFPþ)
and EPDCs (eYFPþ) accumulate together at the IZ, where they elongate and form a ﬁbrillar mesh (G); this damage-dependent accumulation is most evident at the BZ
(H, dotted line). The RZ presents low numbers of nonclustered, dispersed mRFPþ and eYFPþ cells (I), equivalent to those found in normal hearts (see also Figure 1).
Scale bars: B to F, 400 mm; F’, 250 mm; F’’, 300 mm; G, 10 mm; H and I, 30 mm. Double-headed arrows in 2C to E mark the thickness of the ventricular myocardial wall.
BZ ¼ border zone; IZ ¼ infarct zone; RZ ¼ remote zone; other abbreviations as in Figure 1.
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2061cells were found at any stage analyzed, ruling out cell
fusion in our experiments. Between 3 and 7 days post-
MI, large numbers of cardiomyocytes were lost in the
IZ and the density of eYFPþ EPDCs increased in theinfarct area, correlating with an evident thinning of
the free left ventricular wall (from 1.48  0.21 mm in
control animals to 0.7  0.10 mm 1 week post-MI)
(Figures 2C and 2D). One week after MI, large
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mRFPþ BMCs (Figures 2E and 2F) constituted most of
the IZ tissue (Figure 2G), which is ﬂanked by a border
zone (BZ) containing living cardiomyocytes
(Figure 2H). The remote zone (RZ), distant from the IZ,
contained a few loosely distributed eYFPþ and mRFPþ
cells in a pattern similar to that found in control
samples (Figure 2I). At 14 days after MI, a deeply
remodeled left ventricular wall matured into a ﬁbrotic
scar (Figure 2E). This condition persisted 30 days
post-MI (Figure 2F).
CF SOURCE. Detailed histological inspection of
infarcted hearts reveals characteristic spatiotemporal
cellular dynamics at the IZ. One day after MI, both
EPDCs and BMCs showed a random distribution
(Figure 3A). BMCs expressed variable levels of CD45
(Figures 3B to 3B’’’), and were the predominant cell
type at the damage core (mRFP/eYFP cell ratio, 3.1 
0.49; mRFP/eYFP cell ratios in the BZ and RZ, 2.1 
0.52 and 0.3  0.43, respectively). During the ﬁrst day
post-MI, monocytes were abundant in both systemic
(not shown) and coronary blood vessels (Figure 3C).
Monocytes extravasated from the endocardium and
coronary endothelium to the underlying ventricular
interstitium, which contained high numbers of eYFPþ
EPDCs (Online Figures 3A to 3C). A fraction of these
monocytes could differentiate into the mRFPþ/F4/
80þ macrophages accumulating at the IZ (Figure 3D).
Three days after MI, the number of EPDCs had
increased with respect to BMCs (mRFP cells/eYFP
cells ratio, 1.57  0.26; mRFP/eYFP cell ratio, 1.7 
0.38 for the BZ and 0.5  0.61 for the RZ), and both
cell types established close contact, starting to
polarize (Figure 3E). One week after MI, the number of
EPDCs and BMCs at the IZ was similar (mRFP/eYFP
cell ratio, 0.97  0.18; mRFP/eYFP cell ratios in the BZ
and RZ, 0.7  0.22 and 0.4  0.56, respectively). Both
cell types were tightly packed and completely polar-
ized, the long cell axes of EPDCs and BMCs lying in
parallel. Except for some CD31þ capillary endothelial
cells, eYFPþ EPDCs and mRFPþ BMCs were 90.2 
2.1% of cells present at the IZ core 1 week after MI
(Figure 3F).
FACS analysis of CD45þ cells from control and
infarcted hearts (7 days post-MI) conﬁrmed a 10%
decrease in B220þ B cells (of total CD45þ cells) and a
signiﬁcant increase of Mac1þ/Gr1- monocytes (18% of
total CD45þ cells) (Figures 3G and 3H), multipotent
bone marrow (Lin-/cKitþ/Sca1þ/Flk2þ/CD34þ, 34%),
and megakaryocyte-erythrocyte progenitors (Lin-/
cKitþ/Sca1-/FCgRlow/CD34-, 9%) (Figure 3H’) in injured
hearts (all these data are summarized in Online
Figure 3D). Increased numbers of long-termhematopoietic stem cells (LT-HSC; cKitþ/Sca1þ/
CD34-/Flk2-, 2%) in infarcted hearts (ﬁrst week after
MI) were also recorded (Figure 3H’). As compared
with the RZ (Figure 3I), the IZ EPDC population
mostly comprises eYFPþ/CD31-/a-SMAlow ﬁbroblasts,
although some eYFPþ/CD31þ (endothelial) and eYFPþ/
a-SMAþ (myoﬁbroblasts) were present (Figure 3J).
FACS analysis of eYFPþ cells from infarcted hearts
revealed a signiﬁcant rise (45%) in the interstitial
eYFPþ/CD31-/CD90þ population (Figure 3K).
During this period, accumulation of eYFPþ EPDCs
at the IZ correlated with massive extracellular
collagen I protein deposition in the area (Figure 3L).
Accordingly, data from quantitative polymerase chain
reaction analysis of eYFPþ/CD31- cells sorted from
infarcted hearts showed an increase of 3 orders of
magnitude in collagen I transcription with respect to
control samples. However, collagen I messenger
ribonucleic acid in CD45þ bone marrow derivatives
was very low or undetectable at these stages
(Figure 3M). During the third and fourth weeks after
MI, the ventricular wall still hosted high numbers of
BMCs (Figures 3N and 3O), but the cellular structure of
the forming ﬁbrotic scar remained constant: IZ mRFP/
eYFP cell ratio was 0.8  0.04 14 days after MI and
0.9  0.08 30 days after MI. Two weeks post-MI,
mRFP/eYFP cell ratios were 0.8  0.49 for the BZ
and 0.5  0.37 for the RZ; 4 weeks after MI, the BZ and
RZ mRFP/eYFP ratios were 0.7  0.36 and 0.4  0.74,
respectively. Massive extracellular deposition of
collagen I ﬁbers, arranged in parallel to the major axis
of elongated eYFPþ EPDCs, and progressive decellu-
larization of the IZ were evident in this phase
(Figure 3P), in which proinﬂammatory cytokine
(interleukin-6, tumor necrosis factor-a) accumulation
overlapped with BMCs (Online Figures 3E and 3F).
Both multipotent bone marrow progenitors and LT-
HSCs signiﬁcantly decreased between 7 and 30 days
after MI. However, whereas multipotent bone marrow
progenitors fell to levels similar to that of control
animals, LT-HSC numbers remained signiﬁcantly
elevated with respect to control animals 1 month after
MI (Online Figures 3G and 3H). Total changes in BMC/
EPDC ratios (during 1 month after MI) are shown in
Figure 3Q.
To further conﬁrm that Wt1-eYFPþ CFs in the
infarcted heart differentiated from resident intersti-
tial cells and not from adult epicardial epithelial
to mesenchymal transition reactivation, we checked
the expression of epicardial markers, such as Wt1,
cytokeratins, and Raldh2, in the eYFPþ sub-
epicardium of infarcted hearts. As shown in Online
Figures 3I to 3K, no signiﬁcant expression of these
markers could be traced from the epicardium to
FIGURE 3 Epicardium-Derived CFs Build up Infarction Scar
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(A) eYFPþ EPDCs and mRFPþ BMCs shown at the IZ 1 day after MI. (A’, B, B’, B’’, B’’’) Most mRFPþ BMCs are CD45þ, including monocytes (C) and macrophages (D). (E)
Early polarization of RFPþ and YFPþ cells (3 days post-MI) becomes evident 7 days after MI (F). CD31 staining shows that BMCs are not circulating (F); some BMCs are
F4/80þ macrophages (G). FACS of CD45þ cells sorted from infarcted and control hearts shows a rise in Mac1þ/Gr1- monocytes after MI (H). FACS analysis of the cKitþ/
Sca1þ fraction identiﬁes cardiac Flk2þ/CD34þ multipotent bone marrow progenitors, FCgRlow/CD34- megakaryocyte-erythrocyte progenitor, and CD34-/Flk2- LT-HSCs
after MI (H’, red [ signiﬁcant changes). Seven days after MI, IZ EPDCs, but not RZ EPDCs, equal BMCs (I compared with J). IZ EPDCs are eYFPþ/CD31-/a-SMAlow
(J, arrowheads) and CD90þ (K). Up-regulation of extracellular and intracellular collagen (L) is conﬁrmed by Col I mRNA increase in EPDCs, but not BMCs, after MI (M).
IZ BMC/EPDC packing is maintained 14 (N) and 30 (O) days after MI, and Col I deposition precedes decellularization of the IZ (P). (Q) Post-MI BMC/EPDC changes
were signiﬁcant early, between 2 time periods within the ﬁrst week, but relatively ﬂat for the rest of the month. *p < 0.05. Scale bars: A to C, E, and L, 15 mm; B’’’ and F,
10 mm; I and J, 5 mm; N and O, 90 mm; P, 12 mm; A’, 2.5 mm. CF ¼ cardiac ﬁbroblast; LT-HSC ¼ long-term hematopoietic stem cell; MEP ¼ megakaryocyte-erythroid
progenitor; MPP ¼ multipotent hematopoietic progenitor; mRNA ¼ messenger ribonucleic acid; ST-HSC ¼ short-term hematopoietic stem cell; other abbreviations as in
Figures 1 and 2.
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2064the subepicardium at any stage studied (3 to 7 days
post-MI).
EPDC CONTRIBUTION TO CF. Because recent reports
have separately involved epicardial (18) and bone
marrow derivatives (19) in nonischemic ﬁbrosis,
we decided to evaluate eYFPþ EPDC contribution to
cardiac ﬁbrosis in this context. We thus induced hy-
pertension in Wt1Cre-eYFPþ mice via angiotensin II
subcutaneous infusion. Surprisingly, this treatment
yielded a low number of epicardial-derived (eYFPþ)
CFs to hypertensive heartﬁbrosis (Online Figures 4A to
4C), a ﬁnding that differs from those reported after
transaortic constriction-induced pressure overload,
which showed a signiﬁcant epicardial contribution
to CF (20,21).
One week after MI, cKitþ (CD117þ) mRFPþ BMCs
were found embedded in the eYFPþ EPDC-rich tissuearrow Progenitor Proﬁles, Cell Proliferation, and Recruitment
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conﬁrmed the increase in bone marrow–derived
cKitþ progenitors and primitive HSCs (Lin-/Sca1þ/
cKitþ) in the experimental group, and their subse-
quent decrease 1 month after MI (Figure 4B).
Prompted by the characteristic association between
cKitþ BMCs and eYFPþ EPDCs, we investigated
BMC-EPDC interaction in vitro. Coculture of mono-
nuclear enhanced green ﬂuorescent protein bone
marrow cells and a continuous embryonic epicardial
cell line (EPIC) (22), revealed the preferential
attachment of enhanced green ﬂuorescent protein
mononuclear BMCs to EPIC (23.11  3.5% of total
cultured cells) when compared with mononuclear
BMC-tracheal smooth muscle cells cocultures (3.9%F F’
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CENTRAL ILLUSTRATION Origin of Fibroblasts in the Infarcted Heart
Ruiz-Villalba, A. et al. J Am Coll Cardiol. 2015; 65(19):2057–66.
This illustration depicts the interaction and spatial arrangement of epicardium-derived cells (EPDC) (green) and bone marrow–derived cells (orange) as they build up
post-myocardial infarction (MI) scar, expanding from the central infarct zone (IZ) to the adjacent border zone (BZ). The chemotactic stromal cell–derived factor (SDF)-1a
gradient is shown in blue. RFP ¼ red ﬂuorescent protein; RZ ¼ remote zone; YFP ¼ yellow ﬂuorescent protein.
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Figures 5A to 5D).
Phosphohistone H3 immunohistochemistry in our
samples identiﬁed mitotic cells in both mRFPþ BMC
and eYFPþ EPDCs between the IZ and BZ compart-
ments (Figures 4C’ to C’’’’ and 4D). To test whether
chemotaxis could be involved in eYFPþ EPDC
accumulation at the IZ, we isolated eYFPþ EPDCs
from control and infarcted hearts and found that
CXCR4 messenger ribonucleic acid transcription in
eYFPþ cells was increased by 2 orders of magnitude
in infarcted hearts (Figure 4E). To conﬁrm that
eYFPþ EPDCs can respond to SDF-1a signals,
patterned SDF-1a delivery to Wt1Cre-YFP heart walls
was carried out. Accumulation of eYFPþ EPDC around
the SDF-1a source conﬁrmed a robust migratory
response of these cells toward this chemokine
(Figures 4F and F’).
DISCUSSION
In this study we aimed to identify the origin of CFs in
the infarcted heart (Central Illustration). Our genetic
cell-tagging strategy allowed us to trace epicardial-
derived mesenchymal cells (Wt1Cre-eYFPþ) from the
embryonic to the adult cardiac interstitium and
identify the eYFPþ/CD31-/CD90þ cell fraction as the
major source of CF after MI. Although CF differenti-
ation from epicardial epithelial to mesenchymal
reactivation after MI cannot be ruled out (10), our
data indicate that this is not the main mechanism
responsible for the expansion of epicardial-derived
CFs in the ischemic heart, which seems to take placeby proliferation and local recruitment of eYFPþ/
CD31-/CD90þ cells via the myocardially secreted che-
mokine SDF-1a (23). The reported changes in the
BMC/EPDC ratio (falling from 3.1 to 0.97 at 1 week
after MI) illustrate the cellular dynamics of the re-
modeling ventricle and clearly show that the massive
increase of EPDCs in the IZ follows the recruitment of
BMCs to the damage site.
We have also provided data showing that BMC
contribution to the CF population after MI is a minor
one. However, we suggest that BMC-EPDC interaction
is involved in triggering the critical transition from
reparative ﬁbrosis to malignant scarring in the
infarcted heart. All these results, which are in accord
with the genetic expression proﬁle of the cardiac
interstitium after MI (15), do not necessarily argue
against the reported differentiation of circulating
cells (24) or endothelial cells (25) into CFs, but point
to the necessity of compared collagen synthesis
quantiﬁcation to establish the speciﬁc contribution of
deﬁned cell populations to the building of the extra-
cellular matrix in ischemic and nonischemic cardiac
ﬁbrosis.
STUDY LIMITATIONS. Our study is limited by
the technical restrictions of multiple cell lineage
tracing, because it is very difﬁcult to label more
than 2 cell types at the same time, but also by the
challenging histological identiﬁcation of some spe-
ciﬁc hematopoietic cell surface markers. Further
research is needed to identify all the cell types
participating in ventricular remodeling and scarring
after MI.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Fibrosis is a hallmark of post-infarction ventricular
remodeling, but most therapies fail to control ﬁbrosis.
TRANSLATIONAL OUTLOOK: Recognition that
most cardiac ﬁbroblasts in the ischemic heart origi-
nate in the epicardium may stimulate research to
identify pharmacological targets that inhibit
myocardial ﬁbrosis among survivors of myocardial
infarction.
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Our work unambiguously shows that the epicardial-
derived interstitial cell population includes a pool
of ﬁbroblast precursors (CD90þ/CD31-/a-SMAlow/-)
that massively differentiate into CFs (CD90þ/CD31-/
a-SMAlow) after MI. We have thus identiﬁed the
epicardium as the main source of CFs in the ischemic
heart. Moreover, our data indicate that EPDC-BMC
interaction provides the cellular scaffolding required
for patterned collagen deposition in the post-MI
ﬁbrotic scar. We believe that the manipulation of
this cellular interaction could help to minimize car-
diac ﬁbrosis and improve cell-based therapies to
repair the infarcted heart.
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